Sentences with phrase «represented life science companies»
Previously, Erik was an attorney at the law firm of Perkins Coie LLP, where he represented life science companies in the negotiation of financing transactions, joint ventures, research collaborations, licensing arrangements, and manufacturing agreements.
http://www.idri.org/
Rowan Freeland, an intellectual property partner at the law firm Simmons & Simmons, which mostly represents life science companies, says that the new court may also make European patents stronger by making them cheaper to enforce.
Not exact matches
Represented venture capital fund in its investment and purchase of preferred stock of various life science companies in which it is lead investor.
Approximately one in four venture dollars now invested in life science companies in the United States goes to companies focused on the brain and nervous system, which represents a more than threefold increase since 1999, according to the NeuroInsights report.
A small sample of companies Chris has represented in publicly filed matters includes: Wells Fargo, N.A., Future Income Payments, LLC, Meridian Senior Living, Mecklenburg County, Caliber Home Loans, Inc., Grandfather Home for Children, Inc., Branch Bank and Trust Corp., AscendOne Corp., Mecklenburg County, UNC Health Systems, Consert, Inc., Snug Harbor on Nelson Bay, Inc., and Bayer Crop Science.
Foley Hoag's Litigation team was described as having ``... strong experience representing companies in the life sciences, technology and energy industries... a well - known and respected firm with a deep bench of efficient litigators.»
Represented a variety of life science and health care companies, as well as individual employees, officers, consultants and medical professionals, in criminal and civil litigation by multiple U.S. Attorneys Offices, DOJ, HHS - OIG, qui tam Relators, state attorneys general and national Medicaid fraud control units, regarding alleged «off - label» promotion, unlawful inducements and other sales, marketing, pricing and development activities.
currently representing a Fortune 500 company in the life sciences industry regarding non-resident withholding tax assessments totalling approximately $ 100 million in relation to a cross-border distribution.
We represent public and private high - growth companies of all sizes in the technology, health care, life sciences, consumer products, media and medical devices industries.
Mr. Smith represents private companies in a broad range of industries and sectors, including venture capital, life sciences, software, internet, real estate, manufacturing, retail, telecommunications and energy (including oil and gas).
Law360 published an expert analysis article by Laura Vogel and Bella Satra, attorneys in Barclay Damon's Intellectual Property Litigation Practice Area who have extensive experience representing pharmaceutical and other life sciences companies.
He represents numerous companies in the high - tech and life sciences sectors and has significant experience representing sovereign and institutional investors in their investing activities in Asia and elsewhere.
We represent life sciences entrepreneurs in a range of industries, including biotech and specialty pharmaceutical companies, industry associations and academic research institutions, medical device manufacturers, food and nutritional companies, and healthcare service providers.
Quinn Emanuel's life sciences attorneys represent pharmaceutical, biotechnology, medical device, and other life sciences companies from around the world.
Dr. Jarrell has experience representing all types of companies and institutions at all stages of the life sciences business lifecycle, as well as those who invest in them.
Our reputation in environmental law is founded on an in depth understanding of the varied legal, technical and policy issues facing our clients, cost - effective staffing of environmental matters, utilizing the resources of a diverse international firm and an intimate familiarity with the energy, technology, chemical, manufacturing and life sciences companies we represent.
Dr. Jarrell has experience representing companies and institutions at all stages of the life sciences business lifecycle, as well as those who invest in them.
She has more than a dozen years of experience representing leading technology and life sciences companies in high stakes patent infringement, trade secret, and breach of contract litigation in federal courts across the country.
Life Sciences: represents and advises life sciences clients on various corporate matters including negotiating investments, mergers and acquisitions, public offerings and assisting with corporate and business development strategies for early - stage life science and emerging life sciences companLife Sciences: represents and advises life sciences clients on various corporate matters including negotiating investments, mergers and acquisitions, public offerings and assisting with corporate and business development strategies for early - stage life science and emerging life sciences companlife sciences clients on various corporate matters including negotiating investments, mergers and acquisitions, public offerings and assisting with corporate and business development strategies for early - stage life science and emerging life sciences companlife science and emerging life sciences companlife sciences companies.
He has a wealth of experience and deep knowledge representing Chinese companies and Chinese government agencies in US regulatory compliance matters and litigation across a number of industry sectors including pharmaceutical, life sciences, manufacturing and retail.
Our corporate attorneys represent clients in the biotechnology and life sciences industry regardless of whether those clients are not - for - profit entities, emerging companies or multi-million dollar private or public companies.
These attorneys also represent early and mid-stage companies in the biotechnology, bioinformatics, medical device and life sciences industries.
We represent companies that range in size from small technology start - ups to Fortune 1000 companies across a wide spectrum of industries, including software, life sciences, medical devices, professional services, financial services, construction, manufacturing, retail, non-profit and healthcare.